PXDAILY PXS
Rejuvenate / Repair

Research snapshot · 7/8/26

UTHRUnited Therapeutics

Xenotransplantation, manufactured organs
Open UTHR in Robinhood ↗
WATCH
Conviction●●●○○3 of 5
Research target$678.21Snapshot target
Thesis statusINTACTLast reviewed 7/8/26
Market cap$23.53BSnapshot value
Research history

What changed

See all UTHR changes ↗

Conviction
1 → 3

Target
— → $678.21

Thesis status
NEEDS_MORE_DATA → INTACT

Last reviewed
Not reviewed → 7/8/26

Target
— → $678.21

The thesis

Xenotransplantation + manufactured organs. Only public organ-supply play. If organ manufacturing works, demand for the entire toll-road stack compounds.

Catalysts

Xenotransplantation clinical progress; manufactured organ pipeline; organ shortage crisis (~100k+ US waiting list); regulatory pathway advancement.

What breaks it

Binary clinical outcomes; organ rejection risk; regulatory uncertainty; long timelines; single-product concentration risk.

Social sentiment

needs X/Reddit sentiment sweep

Snapshot · 7/8/26
Smart money

🟡 Mixed · ins-$11.3M · 13F 16+/9- · short↑0.25

Snapshot · 7/8/26